Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jul;34(7):1381-6.
doi: 10.1128/AAC.34.7.1381.

Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis

C A Bell  1 , J E Hall, D E Kyle, M Grogl, K A Ohemeng, M A Allen, R R Tidwell
Affiliations

Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis

C A Bell et al. Antimicrob Agents Chemother. 1990 Jul.

Abstract

The antiprotozoal compound 1,5-di(4-amidinophenoxy)pentane (pentamidine) and 36 of its analogs were screened for in vitro activity against Leishmania mexicana amazonensis clone 669 C4S (MHOM/BR/73/M2269) and Plasmodium falciparum clones W2 (Indochina III/CDC) and D6 (Sierra Leone I/CDC). Pentamidine and each of the analogs tested exhibited activity in vitro against L. m. amazonensis and P. falciparum. The pentamidine analogs were more effective against the P. falciparum clones than against L. m. amazonensis. P. falciparum was extremely susceptible to these compounds, with 50% inhibitory concentrations as low as 0.03 microM. While none of the analogs exhibited marked improvement in antileishmanial activity compared with pentamidine, 12 of the pentamidine analogs showed activity approximately equal to or greater than that of the parent compound. From the promising activity exhibited by the pentamidine analogs in this in vitro study and their potential for reduced toxicity relative to the parent drug, pentamidine-related compounds hold promise as new agents for the treatment of protozoal infections.

PubMed Disclaimer

References

    1. J Clin Invest. 1988 Dec;82(6):2011-6 - PubMed
    1. Exp Parasitol. 1989 Jul;69(1):78-90 - PubMed
    1. J Med Chem. 1990 Apr;33(4):1252-7 - PubMed
    1. Antimicrob Agents Chemother. 1990 Jun;34(6):1026-30 - PubMed
    1. Monatsschr Kinderheilkd. 1958 Jan;106(1):10-4 - PubMed

Publication types

MeSH terms

LinkOut - more resources